Overview
- Chest pain/discomfort is often thought as symptom for myocardial infarction or coronary heart disease, and pushes many to seek emergency medical care. Traditional diagnosis method takes 6 hours to confirm and emergency room congestion incurs.
- Based on the basis of magnetocardiography research, developed a non-forced multi-channel ECG detection system
- A rapid diagnosis can be completed in just 10-15 minutes, reduces hospital observation and medical resource consumption
Development Process
During the incubation program completed a multi-channel ECG detection prototype and TFDA IRB clinical approval, currently undergoing human clinical trial and in March 9, 2020 formed MECG BIOTECHNOLOGY LTD.